We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

In this article, we are going to take a look at where Sana Biotechnology, Inc. (NASDAQ:SANA) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation ...

Sana Biotechnology shares last traded at $3.29, with a volume of 1,449,717 shares trading hands. Analyst Upgrades and Downgrades SANA has been the topic of a number of recent analyst reports.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sana Biotechnology has a 1 year low of $1.52 and a 1 year high of $12.00. Sana Biotechnology ( NASDAQ:SANA – Get Free Report ) last issued its quarterly earnings results on Friday, November 8th.

Morgan Stanley raised the firm’s price target on Sana Biotechnology (SANA) to $12 from $9 and keeps an Overweight rating on the shares. Based on the recent type one diabetes update, the firm ...

Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor attention.